EMBRYONIC STEM CELL IN DRUG TOXICITY: GENETICALLY ENGINEERED VERSUS NON-GENETICALLY ENGINEERED CELLS IN CARDIOTOXICITY MODEL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

DEHGHANI L.; FAROKHPOUR M.; TAHANI S.; NASR ESFAHANI M.H.; BAHARVAND H.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Cell Journal (Yakhteh) Year:2013 | Volume:15 | Issue:SUPPLEMENT 1 Page(s): 38-38

Download Full-Text

View:

222

Download:

Cites:

Information Journal Paper

Title

EMBRYONIC STEM CELL IN DRUG TOXICITY: GENETICALLY ENGINEERED VERSUS NON-GENETICALLY ENGINEERED CELLS IN CARDIOTOXICITY MODEL

Author(s)

DEHGHANI L. | FAROKHPOUR M. | TAHANI S. | NASR ESFAHANI M.H. | BAHARVAND H.

Keywords

EMBRYONIC STEM CELLS

CARDIOMYOCYTE DIFFERENTIATION

CYTOTOXICITY

DOXORUBICIN

DEXAMETHASONE

Abstract

Objective: EMBRYONIC STEM CELLS (ESCs) have various uses in drug toxicity, as they can be easily differentiated in vitro. However, one of the major obstacles in the assessment of these differentiated cells is the presence of a heterogeneous cell population.Materials and Methods: To circumvent this problem, purified ESC-derived desired cells by means of the tissuespecific GFP and/or antibiotic resistance gene expression has been proposed. Therefore, this study aimed to assess the role of DOXORUBICIN (DOX) in cardiotoxicity by using genetically and non-genetically engineered ESC-derived cardiomyocytes.Results: The results of this study revealed that both cell lines were suitable for evaluation of DOX cardiotoxicity. This study showed that DOX cardiotoxicity was reduced as detected by beating cardiomyocytes and caspase activity only by pretreatment with DEXAMETHASONE (DEX) and enhances cardiomyocyte-specific gene expression. Conclusion: Therefore, for the general assessment of CYTOTOXICITY, non-genetically engineered ESC-derived cardiomyocytes are sufficient but for the molecular assessment of DOX-induced toxicity, genetically engineered purified ESC-derived cardiomyocytes are necessary.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

DEHGHANI, L., FAROKHPOUR, M., TAHANI, S., NASR ESFAHANI, M.H., & BAHARVAND, H.. (2013). EMBRYONIC STEM CELL IN DRUG TOXICITY: GENETICALLY ENGINEERED VERSUS NON-GENETICALLY ENGINEERED CELLS IN CARDIOTOXICITY MODEL. CELL JOURNAL (YAKHTEH), 15(SUPPLEMENT 1), 38-38. SID. https://sid.ir/paper/617067/en

Vancouver: Copy

DEHGHANI L., FAROKHPOUR M., TAHANI S., NASR ESFAHANI M.H., BAHARVAND H.. EMBRYONIC STEM CELL IN DRUG TOXICITY: GENETICALLY ENGINEERED VERSUS NON-GENETICALLY ENGINEERED CELLS IN CARDIOTOXICITY MODEL. CELL JOURNAL (YAKHTEH)[Internet]. 2013;15(SUPPLEMENT 1):38-38. Available from: https://sid.ir/paper/617067/en

IEEE: Copy

L. DEHGHANI, M. FAROKHPOUR, S. TAHANI, M.H. NASR ESFAHANI, and H. BAHARVAND, “EMBRYONIC STEM CELL IN DRUG TOXICITY: GENETICALLY ENGINEERED VERSUS NON-GENETICALLY ENGINEERED CELLS IN CARDIOTOXICITY MODEL,” CELL JOURNAL (YAKHTEH), vol. 15, no. SUPPLEMENT 1, pp. 38–38, 2013, [Online]. Available: https://sid.ir/paper/617067/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops